Edition:
United States

Nice Ltd (NICE.TA)

NICE.TA on Tel Aviv Stock Exchange

27,560.00ILa
7:47am EDT
Change (% chg)

-40.00 (-0.14%)
Prev Close
27,600.00
Open
27,460.00
Day's High
27,730.00
Day's Low
27,350.00
Volume
60,855
Avg. Vol
82,905
52-wk High
28,870.00
52-wk Low
23,930.00

NICE.TA

Chart for NICE.TA

About

NICE Ltd., formerly NICE-Systems Ltd., is a global enterprise software provider. The Company's segments include Customer Interactions Solutions, and Financial Crime and Compliance Solutions. The Customer Interactions Solutions segment provides data driven insights that enable businesses to deliver personalized experience to... (more)

Overall

Beta: 0.94
Market Cap(Mil.): ₪16,664.89
Shares Outstanding(Mil.): 60.35
Dividend: 58.64
Yield (%): 0.85

Financials

  NICE.TA Industry Sector
P/E (TTM): 46.85 34.25 1,972.53
EPS (TTM): 5.89 -- --
ROI: 5.37 13.98 13.93
ROE: 6.54 14.54 14.53

UK finds Roche bladder cancer drug too costly for routine use

LONDON Britain's healthcare cost-effectiveness agency NICE has decided Roche's new immunotherapy drug Tecentriq is too expensive to justify its routine use to treat bladder cancer, but still hopes it can be used in certain circumstances.

Aug 02 2017

UK finds Roche bladder cancer drug too costly for routine use

LONDON, Aug 2 Britain's healthcare cost-effectiveness agency NICE has decided Roche's new immunotherapy drug Tecentriq is too expensive to justify its routine use to treat bladder cancer, but still hopes it can be used in certain circumstances.

Aug 02 2017

BRIEF-Nice reports 35 pct growth in Q1 revenue

* Nice reports 35 pct growth in revenue for the first quarter 2017

May 04 2017

BRIEF-Nice Ltd says selected for San Francisco Dept Of Emergency Management's 9-1-1 center upgrade

* Nice Ltd - San Francisco Department Of Emergency Management selects Nice for 9-1-1 center upgrade Source text for Eikon: Further company coverage:

Apr 18 2017

Earnings vs. Estimates